Waylis Therap Company Profile

✉ Email this page to a colleague

WAYLIS THERAP has eleven approved drugs.

There is one US patent protecting WAYLIS THERAP drugs.

There are twenty-four patent family members on WAYLIS THERAP drugs in fourteen countries and five supplementary protection certificates in four countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Waylis Therap	LUNESTA	eszopiclone	TABLET;ORAL	021476-001	Dec 15, 2004	AB	RX	Yes	No		⤷ Subscribe				⤷ Subscribe
Waylis Therap	LEUKERAN	chlorambucil	TABLET;ORAL	010669-002	Approved Prior to Jan 1, 1982		RX	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Waylis Therap	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	AB	RX	Yes	No	8,101,209*PED	⤷ Subscribe			Y	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-002	Sep 14, 1995	5,902,821*PED	⤷ Subscribe
Waylis Therap	COREG CR	carvedilol phosphate	CAPSULE, EXTENDED RELEASE;ORAL	022012-004	Oct 20, 2006	RE40000*PED	⤷ Subscribe
Waylis Therap	COREG	carvedilol	TABLET;ORAL	020297-002	Sep 14, 1995	5,760,069*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.5 mg	➤ Subscribe	2007-10-29
➤ Subscribe	Tablets	1 mg, 2 mg and 3 mg	➤ Subscribe	2008-12-15
➤ Subscribe	Extended-release Capsules	10 mg and 20 mg	➤ Subscribe	2008-03-18
➤ Subscribe	Extended-release Capsules	80 mg	➤ Subscribe	2007-11-19
➤ Subscribe	Capsule	0.5 mg/0.4 mg	➤ Subscribe	2010-10-26
➤ Subscribe	Extended-release Capsules	40 mg	➤ Subscribe	2007-12-21

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0719278	23/2003	Austria	⤷ Subscribe	PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719
0719278	03C0030	France	⤷ Subscribe	PRODUCT NAME: DUTASTERIDE; NAT. REGISTRATION NO/DATE: NL 28 131 20030327; FIRST REGISTRATION: SE - 17 871 20020719
0268956	SPC/GB98/040	United Kingdom	⤷ Subscribe	PRODUCT NAME: RABEPRAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE SODIUM SALT; REGISTERED: UK 10555/0010 19980508; UK 10555/0008 19980508
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.